Antiplatelet Therapy in Cardiovascular Disease | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Jr.
B01=Michael A. Gaglia
B01=Paul A. Gurbel
B01=Ron Waksman
Category1=Non-Fiction
Category=MJD
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

Antiplatelet Therapy in Cardiovascular Disease

English

Edited by a team of the worlds leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents.

 

This important new book:

  • Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells.
  • Thoroughly covers platelet function testing, including novel techniques.
  • Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease.
  • Reviews all types of antiplatelet agents from aspirin to recently approved drugs including indications, clinical outcomes, and side effects.

 

Written by an international whos who of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists.

See more
Current price €80.74
Original price €84.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Jr.B01=Michael A. GagliaB01=Paul A. GurbelB01=Ron WaksmanCategory1=Non-FictionCategory=MJDCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 708g
  • Dimensions: 159 x 238mm
  • Publication Date: 16 May 2014
  • Publisher: John Wiley and Sons Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781118275757

About

Ron Waksman MD FACC is Associate Director Division of Cardiology and Director of Experimental Angioplasty & New Technologies Washington Hospital Center Washington DC. Dr. Waksman is currently the Editor-in-Chief of Cardiovascular Revascularization Medicine and sits on the editorial boards of six other internationally published journals. He has been Editor/Co-Editor of six books since 1996 and has authored 22 additional book chapters. Dr. Waksman has also authored/co-authored over 250 published manuscripts and over 200 abstracts. He is also a Clinical Professor of Medicine (Cardiology) at Georgetown University Washington DC USA.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept